Latest current cash for 6621.TWO: $20M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest current cash for 6621.TWO is $20M as of June 2026. That compares with $46M in the prior-year period — down 56.5% year over year. Investors often review this figure alongside UniPharma , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Over the past year, 6621.TWO's current cash moved from $46M to $20M — a 56.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in UniPharma , Ltd.'s operating scale or balance-sheet position.
A current cash figure of $20M for 6621.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting 6621.TWO's current cash ($20M), review year-over-year change from $46M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.